HEALTH● LOWAug 19 · Aug 19, 2026, 12:54 PM
Teva gets FDA priority review for Tourette syndrome therapy
Seeking Alpha Tech
Teva Pharmaceuticals has received priority review status from the FDA for its new therapy designed to treat Tourette syndrome, potentially accelerating its approval process.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTHBREAKING1h agoSudan : 10 Dead As WHO Flags Sudan West Kordofan Latest Cholera Outbreak Hotspot allafrica.com · NigeriaHEALTHBREAKING1h agoMajor hub latest city to confirm first case of bird fluareanews.com.au · AustraliaHEALTH1h agoBeyond Firing Blanks : Why a Zero Sperm Count Does Not Mean the End of the Road . newzimbabwe.com · ZimbabweHEALTH1h agoExpired food products seized from Chairman’s Club at Sahakaranagar in Bengaluru, kitchen shut downThe Hindu